Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients

M. Watanabe, S. Tsuru, Sadakazu Aiso, T. Hibi, T. Yoshida, H. Asakura, Y. Zinnaka, M. Tsuchiya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Lymphocyte proliferative response to phytohemagglutinin (PHA) and relevance of serum factors to the response were studied in 12 patients with Crohn's disease (CD). The lymphocyte proliferative response was markedly reduced in patients with Crohn's disease (S.I. = 38.8 ± 36.8) (mean ± SD), as compared with normal controls (S.I. = 100.6 ± 28.6) (p < 0.01). In addition, the effect of sera from patients with CD or 10 patients with ulcerative colitis (UC) who had extremely impaired lymphocyte responsiveness to PHA on the proliferative response to normal lymphocytes to PHA was also measured. Sera from CD patients had a marked suppressive effect on the blastogenesis of normal lymphocytes (S.I. = 46.4 ± 28.5), as compared with normal sera (S.I. = 126.2 ± 14.7) (p < 0.001). On the other hand, UC sera did not suppress the blastogenesis of normal lymphocytes (S.I. = 114.9 ± 27.7). Moreover, serum immunosuppressive acidic protein (IAP) levels in patients' sera were measured by single radial immunodiffusion assay. A marked increase in serum IAP levels was revealed both in CD patients (780 ± 270 μg/ml) and in UC patients (601 ± 278 μg/ml), as compared with normal controls (376 ± 92 μg/ml) (p < 0.001). But there was no precise correlation between the suppressive effect of sera and serum IAP levels in patients with CD. Thus, we demonstrated an impairment of the lymphocyte responsiveness to PHA in CD patients and the possible existence of immunosuppressive factors which is not identical with IAP in the sera from patients with CD.

Original languageEnglish
Pages (from-to)29-34
Number of pages6
JournalJournal of Clinical and Laboratory Immunology
Volume14
Issue number1
Publication statusPublished - 1984 Aug 9
Externally publishedYes

ASJC Scopus subject areas

  • Immunology

Cite this

Watanabe, M., Tsuru, S., Aiso, S., Hibi, T., Yoshida, T., Asakura, H., ... Tsuchiya, M. (1984). Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients. Journal of Clinical and Laboratory Immunology, 14(1), 29-34.

Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients. / Watanabe, M.; Tsuru, S.; Aiso, Sadakazu; Hibi, T.; Yoshida, T.; Asakura, H.; Zinnaka, Y.; Tsuchiya, M.

In: Journal of Clinical and Laboratory Immunology, Vol. 14, No. 1, 09.08.1984, p. 29-34.

Research output: Contribution to journalArticle

Watanabe, M, Tsuru, S, Aiso, S, Hibi, T, Yoshida, T, Asakura, H, Zinnaka, Y & Tsuchiya, M 1984, 'Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients', Journal of Clinical and Laboratory Immunology, vol. 14, no. 1, pp. 29-34.
Watanabe, M. ; Tsuru, S. ; Aiso, Sadakazu ; Hibi, T. ; Yoshida, T. ; Asakura, H. ; Zinnaka, Y. ; Tsuchiya, M. / Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients. In: Journal of Clinical and Laboratory Immunology. 1984 ; Vol. 14, No. 1. pp. 29-34.
@article{49923b9f06e14f50991442065d95d6e8,
title = "Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients",
abstract = "Lymphocyte proliferative response to phytohemagglutinin (PHA) and relevance of serum factors to the response were studied in 12 patients with Crohn's disease (CD). The lymphocyte proliferative response was markedly reduced in patients with Crohn's disease (S.I. = 38.8 ± 36.8) (mean ± SD), as compared with normal controls (S.I. = 100.6 ± 28.6) (p < 0.01). In addition, the effect of sera from patients with CD or 10 patients with ulcerative colitis (UC) who had extremely impaired lymphocyte responsiveness to PHA on the proliferative response to normal lymphocytes to PHA was also measured. Sera from CD patients had a marked suppressive effect on the blastogenesis of normal lymphocytes (S.I. = 46.4 ± 28.5), as compared with normal sera (S.I. = 126.2 ± 14.7) (p < 0.001). On the other hand, UC sera did not suppress the blastogenesis of normal lymphocytes (S.I. = 114.9 ± 27.7). Moreover, serum immunosuppressive acidic protein (IAP) levels in patients' sera were measured by single radial immunodiffusion assay. A marked increase in serum IAP levels was revealed both in CD patients (780 ± 270 μg/ml) and in UC patients (601 ± 278 μg/ml), as compared with normal controls (376 ± 92 μg/ml) (p < 0.001). But there was no precise correlation between the suppressive effect of sera and serum IAP levels in patients with CD. Thus, we demonstrated an impairment of the lymphocyte responsiveness to PHA in CD patients and the possible existence of immunosuppressive factors which is not identical with IAP in the sera from patients with CD.",
author = "M. Watanabe and S. Tsuru and Sadakazu Aiso and T. Hibi and T. Yoshida and H. Asakura and Y. Zinnaka and M. Tsuchiya",
year = "1984",
month = "8",
day = "9",
language = "English",
volume = "14",
pages = "29--34",
journal = "Journal of Clinical and Laboratory Immunology",
issn = "0141-2760",
publisher = "Teviot Scientific Publications Ltd.",
number = "1",

}

TY - JOUR

T1 - Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients

AU - Watanabe, M.

AU - Tsuru, S.

AU - Aiso, Sadakazu

AU - Hibi, T.

AU - Yoshida, T.

AU - Asakura, H.

AU - Zinnaka, Y.

AU - Tsuchiya, M.

PY - 1984/8/9

Y1 - 1984/8/9

N2 - Lymphocyte proliferative response to phytohemagglutinin (PHA) and relevance of serum factors to the response were studied in 12 patients with Crohn's disease (CD). The lymphocyte proliferative response was markedly reduced in patients with Crohn's disease (S.I. = 38.8 ± 36.8) (mean ± SD), as compared with normal controls (S.I. = 100.6 ± 28.6) (p < 0.01). In addition, the effect of sera from patients with CD or 10 patients with ulcerative colitis (UC) who had extremely impaired lymphocyte responsiveness to PHA on the proliferative response to normal lymphocytes to PHA was also measured. Sera from CD patients had a marked suppressive effect on the blastogenesis of normal lymphocytes (S.I. = 46.4 ± 28.5), as compared with normal sera (S.I. = 126.2 ± 14.7) (p < 0.001). On the other hand, UC sera did not suppress the blastogenesis of normal lymphocytes (S.I. = 114.9 ± 27.7). Moreover, serum immunosuppressive acidic protein (IAP) levels in patients' sera were measured by single radial immunodiffusion assay. A marked increase in serum IAP levels was revealed both in CD patients (780 ± 270 μg/ml) and in UC patients (601 ± 278 μg/ml), as compared with normal controls (376 ± 92 μg/ml) (p < 0.001). But there was no precise correlation between the suppressive effect of sera and serum IAP levels in patients with CD. Thus, we demonstrated an impairment of the lymphocyte responsiveness to PHA in CD patients and the possible existence of immunosuppressive factors which is not identical with IAP in the sera from patients with CD.

AB - Lymphocyte proliferative response to phytohemagglutinin (PHA) and relevance of serum factors to the response were studied in 12 patients with Crohn's disease (CD). The lymphocyte proliferative response was markedly reduced in patients with Crohn's disease (S.I. = 38.8 ± 36.8) (mean ± SD), as compared with normal controls (S.I. = 100.6 ± 28.6) (p < 0.01). In addition, the effect of sera from patients with CD or 10 patients with ulcerative colitis (UC) who had extremely impaired lymphocyte responsiveness to PHA on the proliferative response to normal lymphocytes to PHA was also measured. Sera from CD patients had a marked suppressive effect on the blastogenesis of normal lymphocytes (S.I. = 46.4 ± 28.5), as compared with normal sera (S.I. = 126.2 ± 14.7) (p < 0.001). On the other hand, UC sera did not suppress the blastogenesis of normal lymphocytes (S.I. = 114.9 ± 27.7). Moreover, serum immunosuppressive acidic protein (IAP) levels in patients' sera were measured by single radial immunodiffusion assay. A marked increase in serum IAP levels was revealed both in CD patients (780 ± 270 μg/ml) and in UC patients (601 ± 278 μg/ml), as compared with normal controls (376 ± 92 μg/ml) (p < 0.001). But there was no precise correlation between the suppressive effect of sera and serum IAP levels in patients with CD. Thus, we demonstrated an impairment of the lymphocyte responsiveness to PHA in CD patients and the possible existence of immunosuppressive factors which is not identical with IAP in the sera from patients with CD.

UR - http://www.scopus.com/inward/record.url?scp=0021276023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021276023&partnerID=8YFLogxK

M3 - Article

C2 - 6748044

AN - SCOPUS:0021276023

VL - 14

SP - 29

EP - 34

JO - Journal of Clinical and Laboratory Immunology

JF - Journal of Clinical and Laboratory Immunology

SN - 0141-2760

IS - 1

ER -